FluGen (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- August 25, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $12,000,000
Company Info
- Founding Year
- 2005
- Company Description
- FluGen, Inc. is a privately held biotechnology company developing novel influenza vaccine technology. The REDEE FLU vaccine contains mutations in the M2 gene of the virus, allowing it to induce immune responses without shedding infectious virus particles.
- Market
- Influenza vaccine development
- Location
- Madison, Wisconsin, USA
- Coinvestors
- State of Wisconsin Investment Board, Venture Investors, Wisconsin Alumni Research Foundation